Brebnor L D, Grimm J, Balinsky J B
Cancer Res. 1981 Jul;41(7):2692-9.
The levels of the five enzymes of the urea cycle were measured in normal 5-week-old rats, in a transplantable hepatoma, and in the livers of tumor-bearing rats (host livers). The levels of all five enzymes were much lower in the hepatoma, although there was no exact correlation of the decrease in levels. In host livers, the levels were higher than in the tumors, but lower than in normal liver. The levels of all five urea cycle enzymes were positively correlated with dietary protein content in normal livers, in hepatomas, and in host livers. In fact, the hepatomas showed the greatest changes in response to diet. On all diets, the levels in host liver remained below those in normal liver, indicating that the decreased level was probably not due to preferential utilization of nutrients by the tumor. The levels of urea cycle enzymes in normal liver were not altered by a single injection of glucocorticoid, glucagon, or dibutyryl cyclic adenosine 3':5'-monophosphate. By contrast, in hepatoma, the levels were usually significantly elevated by the same treatment. In addition, the levels in host livers were always significantly elevated and were usually above those in normal animals, whether the latter were hormone treated or not. Injection of plasma from tumor-bearing rats into normal animals produced a decrease in the levels of all five enzymes; if glucagon was injected together with the plasma, large increases in levels were observed. This result supports the concept of a humoral factor produced by the tumor which affects the levels and the inducibility of urea cycle enzymes in host livers. Autopsied human primary hepatomas also showed levels of urea cycle enzymes below those in normal livers with host livers having intermediate values. A cell line derived from a human hepatoma showed induction of arginase by glucocorticoid in culture; in this, it resembled a cell line of the rat hepatoma. Tyrosine aminotransferase in human hepatoma cells was not induced by glucocorticoid; in this, it differed from the rat hepatoma cells where induction of this enzyme was observed.
在5周龄的正常大鼠、一种可移植性肝癌以及荷瘤大鼠的肝脏(宿主肝脏)中,检测了尿素循环中五种酶的水平。肝癌中所有五种酶的水平都低得多,尽管酶水平的降低并无确切的相关性。在宿主肝脏中,这些酶的水平高于肿瘤中的水平,但低于正常肝脏中的水平。在正常肝脏、肝癌和宿主肝脏中,所有五种尿素循环酶的水平都与饮食蛋白质含量呈正相关。事实上,肝癌对饮食的反应变化最大。在所有饮食条件下,宿主肝脏中的酶水平仍低于正常肝脏中的水平,这表明酶水平降低可能并非由于肿瘤优先利用营养物质所致。单次注射糖皮质激素、胰高血糖素或二丁酰环磷腺苷3':5'-单磷酸不会改变正常肝脏中尿素循环酶的水平。相比之下,在肝癌中,相同的处理通常会使这些酶的水平显著升高。此外,无论正常动物是否接受激素处理,宿主肝脏中的酶水平总是显著升高,且通常高于正常动物中的水平。将荷瘤大鼠的血浆注射到正常动物体内会导致所有五种酶的水平下降;如果在注射血浆的同时注射胰高血糖素,则会观察到酶水平大幅升高。这一结果支持了肿瘤产生一种体液因子的概念,该因子会影响宿主肝脏中尿素循环酶的水平和诱导性。经尸检的人类原发性肝癌中尿素循环酶的水平也低于正常肝脏,宿主肝脏中的酶水平则介于两者之间。源自人类肝癌的细胞系在培养中显示糖皮质激素可诱导精氨酸酶;在这方面,它类似于大鼠肝癌的细胞系。人类肝癌细胞中的酪氨酸转氨酶不会被糖皮质激素诱导;在这方面,它与大鼠肝癌细胞不同,在大鼠肝癌细胞中可观察到该酶的诱导现象。